TY  - GEN
AU  - Kurtz,David M
AU  - Tschetter,Loren K
AU  - Allred,Jacob B
AU  - Geyer,Susan M
AU  - Kurtin,Paul J
AU  - Putnam,Wesley D
AU  - Rowland,Kendrith M
AU  - Wiesenfeld,Martin
AU  - Soori,Gamini S
AU  - Tenglin,Richard C
AU  - Bernath,Albert M
AU  - Witzig,Thomas E
TI  - Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51
SN  - 1042-8194
PY  - 2007///0926
KW  - Adult
KW  - Aged
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Interleukin-4
KW  - administration & dosage
KW  - Lymphoma, Non-Hodgkin
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Salvage Therapy
KW  - methods
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1080/10428190701355028
ER  -